April proved to be an unusually strong month for U.S. equities, with headline indexes posting gains rarely seen in a single 30-day span. The S&P 500 advanced roughly 10% while the Nasdaq 100 climbed more than 16%, marking the best month for the S&P 500 since the pandemic. Corporate earnings that materially outperformed expectations were the principal driver behind the surge.
Technology companies led the earnings beat, collectively recording year-over-year EPS growth above 27%. Yet the breadth of opportunity extended beyond tech: stocks in sectors that had lagged, particularly Healthcare, delivered some of the market’s most concentrated upside.
AI-driven selections and April performance
Subscribers to our premium ProPicks service, available for less than $9 per month in the offering cited, received a curated list of AI-identified, high-potential stocks at the start of April. The list saw widespread success: more than sixty of those names produced double-digit rallies over the month alone. Within that broader set, the AI models zeroed in on standout opportunities in Healthcare and Semiconductors that produced particularly large returns.
- Centene (NYSE: CNC) - +58.11% in April alone
- Molina Healthcare (NYSE: MOH) - +43.17% in April alone
- Texas Instruments (NASDAQ: TXN) - +43.16% in April alone
- Qualcomm (NASDAQ: QCOM) - +41.06% in April alone
These four names outpaced the major indexes by a considerable margin during April.
What the AI highlighted before the rallies - selected case studies
The ProPicks engine not only produces a list of names; it returns a structured rationale for each selection based on quantitative signals. Below are the model’s key drivers for two of April’s largest healthcare gainers as presented before their respective surges.
Molina Healthcare (NYSE: MOH)
- Deep value opportunity - At the time of selection, the equity was trading at roughly 37% of its 52-week high, while analyst consensus targets were in a $150–$195 range versus an entry price near $133, suggesting substantial upside.
- Revenue expansion - Total revenue growth of about 11% pushed sales past $43 billion, with the company isolating more than $9 billion in potential new Medicaid contract revenue.
- Earnings power - Management characterized 2025 cost pressures as temporary and signaled embedded earnings power in excess of $11 per share.
- Balance sheet stability - The firm held more cash than debt and earned a "GREAT" financial health rating, a sign the balance sheet could support a corporate turnaround.
Centene (NYSE: CNC)
- Momentum and earnings outperformance - The model flagged rapid market momentum and accelerating growth metrics ahead of a significant quarterly print. The stock rose 58% over the month and 28% in a single week following strong Q1 results.
- Quarterly results - Adjusted EPS of $3.37 exceeded a $2.13 consensus by 58%, and revenue approached $50 billion, both marked as drivers of the immediate re-rating.
- Upgrades and guidance - After the print, full-year guidance was raised and analysts subsequently upgraded the stock with $60 price targets at the firms noted by the model.
- Longer-term earnings outlook - The AI noted potential normalization of Medicaid margins toward a longer-run earnings power in the vicinity of $12 per share and a model-derived fair value of $67 compared with a reference price near $54.
Selection changes for May
Even after April’s significant moves, the AI rebalances monthly. One notable change heading into May: Qualcomm (QCOM), despite returning more than 41% in April, was removed from the May high-conviction list. The reason cited by the model for the removal was summarized as 'Lagging Momentum, Mixed Valuation, Modest Liquidity.' The suite’s rebalancing process is designed to retain top performers while replacing names that no longer meet its composite criteria.
At the same time a fresh list of AI-picked names for May has been published. The AI’s May selections include names such as Teradata and NGL Energy Partners LP, both of which the model reported were showing early positive momentum in the new month and were up nearly 5% at the time of reporting.
Performance since launch and how the engine operates
Since the AI models’ official launch in November 2023, the aggregated list of AI-powered picks is reported to be up +187.52%. That performance represents a +117.33% outperformance relative to the S&P 500 over the same interval, according to the performance figures provided.
The AI selection engine operates on a monthly cadence and evaluates thousands of global equities using a combination of historical and forward-looking signals. Specifically, the system processes more than 15 years of financial data across over 150 quantitative models and applies a mix of valuation, momentum, and growth metrics to identify up to 20 high-conviction stocks per strategy based on medium-term upside potential.
Each strategy is rebalanced monthly: fresh opportunities are added, the strongest performers are retained where appropriate, and names that fail to meet the model’s fundamental thresholds are removed. To provide a consistent benchmark, the strategy uses equal weighting across all selected stocks; individual investors can, of course, choose different allocations.
Subscription access and member notes
For subscribers, the May list is available now. Existing members are directed to the full selection, while non-members are given options to subscribe via the app or web to view the complete May roster and access the data-driven rationale behind each pick. The article notes that subscription prices were accurate at the time of publication and that offers may vary by region.
The engine’s stated objective is systematic: not to capture one-off winners but to continuously reallocate capital toward the strongest opportunities as market conditions evolve.
Context and closing observation
April’s unusual market breadth provided fertile ground for AI-assisted stock selection, enabling sizable gains in both healthcare and semiconductor names. The selection and rebalancing process drove a concentrated set of winners, and the May refresh reflects the engine’s ongoing emphasis on momentum, valuation discipline, and liquidity considerations. As earnings season continues and volatility persists, the model will continue to scan and reshuffle its high-conviction set on a monthly basis.